Hypoxia-induced alveolar epithelial-mesenchymal transition requires mitochondrial ROS and hypoxia-inducible factor 1

被引:190
|
作者
Zhou, Guofei [1 ]
Dada, Laura A. [1 ]
Wu, Minghua [2 ]
Kelly, Aileen [1 ]
Trejo, Humberto [1 ]
Zhou, Qiyuan [3 ]
Varga, John [2 ]
Sznajder, Jacob I. [1 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA
[2] Northwestern Univ, Feinberg Sch Med, Div Rheumatol, Chicago, IL 60611 USA
[3] Univ Illinois, Dept Pediat, Chicago, IL USA
基金
美国国家卫生研究院;
关键词
alveolar epithelial cells; pulmonary fibrosis; transforming growth factor-beta 1; SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR-BETA; TGF-BETA; PULMONARY-FIBROSIS; NADPH OXIDASE; IN-VIVO; OXYGEN; ACTIVATION; EXPRESSION; LUNG;
D O I
10.1152/ajplung.00007.2009
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Zhou G, Dada LA, Wu M, Kelly A, Trejo H, Zhou Q, Varga J, Sznajder JI. Hypoxia-induced alveolar epithelial-mesenchymal transition requires mitochondrial ROS and hypoxia-inducible factor 1. Am J Physiol Lung Cell Mol Physiol 297: L1120-L1130, 2009. First published October 2, 2009; doi:10.1152/ajplung.00007.2009.-Patients with acute lung injury develop hypoxia, which may lead to lung dysfunction and aberrant tissue repair. Recent studies have suggested that epithelial-mesenchymal transition (EMT) contributes to pulmonary fibrosis. We sought to determine whether hypoxia induces EMT in alveolar epithelial cells (AEC). We found that hypoxia induced the expression of alpha-smooth muscle actin (alpha-SMA) and vimentin and decreased the expression of E-cadherin in transformed and primary human, rat, and mouse AEC, suggesting that hypoxia induces EMT in AEC. Both severe hypoxia and moderate hypoxia induced EMT. The reactive oxygen species ( ROS) scavenger Euk-134 prevented hypoxia-induced EMT. Moreover, hypoxia-induced expression of alpha-SMA and vimentin was prevented in mitochondria-deficient rho(0) cells, which are incapable of ROS production during hypoxia. CoCl2 and dimethyloxaloylglycine, two compounds that stabilize hypoxia-inducible factor (HIF)-alpha under normoxia, failed to induce alpha-SMA expression in AEC. Furthermore, overexpression of constitutively active HIF-1 alpha did not induce alpha-SMA. However, loss of HIF-1 alpha or HIF-2 alpha abolished induction of alpha-SMA mRNA during hypoxia. Hypoxia increased the levels of transforming growth factor (TGF)-beta 1, and preincubation of AEC with SB431542, an inhibitor of the TGF-beta 1 type I receptor kinase, prevented the hypoxia-induced EMT, suggesting that the process was TGF-beta 1 dependent. Furthermore, both ROS and HIF-alpha were necessary for hypoxia-induced TGF-beta 1 upregulation. Accordingly, we have provided evidence that hypoxia induces EMT of AEC through mitochondrial ROS, HIF, and endogenous TGF-beta 1 signaling.
引用
收藏
页码:L1120 / L1130
页数:11
相关论文
共 50 条
  • [21] Protective effect of mesenchymal stem cells (MSC) on hypoxia-induced epithelial-mesenchymal transition of alveolar epithelial cells (AEC)
    Uzunhan, Yurdagul
    Randrianarison, Nadia
    Marchant, Dominique
    Dard, Nicolas
    Larghero, Jerome
    Planes, Carole
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [22] Parthenolide suppresses hypoxia induced angiogenesis and epithelial-mesenchymal transition by regulating hypoxia inducible factor 1 α signaling in colorectal cancer
    Kim, S. L.
    Kim, S. W.
    Park, Y. R.
    ANNALS OF ONCOLOGY, 2016, 27 : 39 - 39
  • [23] Hypoxia-Inducible Factor-1α Is Essential for Hypoxia-Induced Mesenchymal Stem Cell Mobilization into the Peripheral Blood
    Liu, Lizhen
    Yu, Qin
    Lin, Jie
    Lai, Xiaoyu
    Cao, Weijie
    Du, Kaili
    Wang, Yingjia
    Wu, Kangni
    Hu, Yongxian
    Zhang, Lifei
    Xiao, Haowen
    Duan, Yanping
    Huang, He
    STEM CELLS AND DEVELOPMENT, 2011, 20 (11) : 1961 - 1971
  • [24] Hypoxia-induced resistance to anticancer drugs is associated with decreased senescence and requires hypoxia-inducible factor-1 activity
    Sullivan, Richard
    Pare, Genevieve C.
    Frederiksen, Lisa J.
    Semenza, Gregg L.
    Graham, Charles H.
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (07) : 1961 - 1973
  • [25] Dexamethasone inhibits hypoxia-induced epithelial-mesenchymal transition in colon cancer
    Kim, Jung Ho
    Hwang, You-Jin
    Han, Sang Hoon
    Lee, Young Eun
    Kim, Saerom
    Kim, Yoon Jae
    Cho, Jae Hee
    Kwon, Kwang An
    Kim, Ju Hyun
    Kim, Se-Hee
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (34) : 9887 - 9899
  • [26] Effect of PACAP on Hypoxia-Induced Angiogenesis and Epithelial-Mesenchymal Transition in Glioblastoma
    Maugeri, Grazia
    D'Amico, Agata Grazia
    Saccone, Salvatore
    Federico, Concetta
    Rasa, Daniela Maria
    Caltabiano, Rosario
    Broggi, Giuseppe
    Giunta, Salvatore
    Musumeci, Giuseppe
    D'Agata, Velia
    BIOMEDICINES, 2021, 9 (08)
  • [27] Dexamethasone inhibits hypoxia-induced epithelial-mesenchymal transition in colon cancer
    Jung Ho Kim
    You-Jin Hwang
    Sang Hoon Han
    Young Eun Lee
    Saerom Kim
    Yoon Jae Kim
    Jae Hee Cho
    Kwang An Kwon
    Ju Hyun Kim
    Se-Hee Kim
    World Journal of Gastroenterology, 2015, 21 (34) : 9887 - 9899
  • [28] Role of Wnt/β-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1α
    Jiang, Yong-Guang
    Luo, Yong
    He, Da-lin
    Li, Xiang
    Zhang, Lin-lin
    Peng, Tao
    Li, Ming-Chuan
    Lin, Yun-Hua
    INTERNATIONAL JOURNAL OF UROLOGY, 2007, 14 (11) : 1034 - 1039
  • [29] Atorvastatin attenuates paraquat poisoning-induced epithelial-mesenchymal transition via downregulating hypoxia-inducible factor-1 alpha
    Du, Jiang
    Zhu, Yong
    Meng, Xiaoxiao
    Xie, Hui
    Wang, Jinfeng
    Zhou, Zhigang
    Wang, Ruilan
    LIFE SCIENCES, 2018, 213 : 126 - 133
  • [30] Hypoxia-inducible factor-1α contributes to hypoxia-induced chemoresistance in gastric cancer
    Liu, Lili
    Ning, Xiaoxuan
    Sun, Li
    Zhang, Hongbo
    Shi, Yongquan
    Guo, Changcun
    Han, Shuang
    Liu, Jie
    Sun, Shiren
    Han, Zheyi
    Wu, Kaichun
    Fan, Daiming
    CANCER SCIENCE, 2008, 99 (01): : 121 - 128